BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397]
URL: https://www.wjgnet.com/1007-9327/full/v22/i17/4397.htm
Number Citing Articles
1
Juan-José Gallego, María-Pilar Ballester, Alessandra Fiorillo, Franc Casanova-Ferrer, Adrià López-Gramaje, Amparo Urios, Yaiza María Arenas, María-Pilar Ríos, Lucía Durbán, Javier Megías, Teresa San-Miguel, Salvador Benlloch, Paloma Lluch, Rajiv Jalan, Carmina Montoliu. Ammonia and beyond – biomarkers of hepatic encephalopathyMetabolic Brain Disease 2025; 40(1) doi: 10.1007/s11011-024-01512-7
2
Bora Dinc, Ilker Onguc Aycan, Mutay Aslan, Necmiye Hadimioglu, Zeki Ertug, Abdullah Kisaoglu, Ismail Demiryilmaz. Evaluation of Preoperative and Postoperative S100β and NSE Levels in Liver Transplantation and Right Lobe Living-Donor Hepatectomy: A Prospective Cohort StudyTransplantation Proceedings 2021; 53(1): 16 doi: 10.1016/j.transproceed.2020.04.1818
3
Yan Wang, Yu-Feng Xue, Yi-Fan Xu, Ming-Wei Wang, Jing Guan, Xi Chen. Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosisMetabolic Brain Disease 2024; 39(6): 1099 doi: 10.1007/s11011-024-01381-0
4
Shanling Mu, Hong Ma, Jun Shi, Dezhi Zhen. The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significanceOncology Letters 2017;  doi: 10.3892/ol.2017.7089
5
Radha K. Dhiman, Sahaj Rathi. Evidence‐based Gastroenterology and Hepatology 4e2019; : 676 doi: 10.1002/9781119211419.ch44
6
Hendrik Strebel, Bernhard Haller, Maximilian Sohn, Wolfgang Schepp, Felix Gundling. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-AspartateGE - Portuguese Journal of Gastroenterology 2020; 27(6): 391 doi: 10.1159/000507225
7
Mariana Verdelho Machado. Liquid Diagnosis of Hepatic Encephalopathy: Are We There Already?GE - Portuguese Journal of Gastroenterology 2020; 27(6): 378 doi: 10.1159/000510059
8
Bae-Hwan Kim, Se-Hoon Jung, Suryun Jung. Beet root (Beta vulgaris) protects lipopolysaccharide and alcohol-induced liver damage in ratToxicological Research 2020; 36(3): 275 doi: 10.1007/s43188-019-00030-4
9
Tarana Gupta, Sahaj Rathi, Radha K Dhiman. Managing Encephalopathy in the Outpatient SettingEuroasian Journal of Hepato-Gastroenterology 2017; 7(1): 48 doi: 10.5005/jp-journals-10018-1211
10
Sahaj Rathi, Radha K. Dhiman. Managing encephalopathy in the outpatient settingClinical Liver Disease 2016; 8(6): 150 doi: 10.1002/cld.590
11
Anna Czarnecka, Marta Obara-Michlewska, Dorota Wesół-Kucharska, Milena Greczan, Magdalena Kaczor, Janusz Książyk, Dariusz Rokicki, Magdalena Zielińska. S100B Protein but Not 3-Nitrotyrosine Positively Correlates with Plasma Ammonia in Patients with Inherited Hyperammonemias: A New Promising Diagnostic Tool?Journal of Clinical Medicine 2023; 12(6): 2411 doi: 10.3390/jcm12062411
12
Carlos Pérez-Monter, Aldo Torre-Delgadillo. Astrocyte - Physiology and Pathology2018;  doi: 10.5772/intechopen.72506
13
Wojciech Pisarek. S100 Beta Protein as a Marker of Hepatic Encephalopathy: A Breakthrough in Diagnostics or a False Trail? Review of the Literature.Postępy Higieny i Medycyny Doświadczalnej 2022; 76(1): 128 doi: 10.2478/ahem-2022-0018